Welcome to LookChem.com Sign In|Join Free
  • or
5-Bromo-2,4-dimethylpyrimidine, a pyrimidine derivative with the molecular formula C6H7BrN2, is a chemical compound featuring a bromine atom and two methyl groups attached to the pyrimidine ring. It is a solid white powder with a molecular weight of 186.04 g/mol. Due to its potential reactivity and toxicity, it is typically handled and stored under controlled conditions.

69696-37-3

Post Buying Request

69696-37-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

69696-37-3 Usage

Uses

Used in Organic Synthesis:
5-Bromo-2,4-dimethylpyrimidine is used as a building block in organic synthesis for the creation of various biologically active compounds. Its unique structure allows for the development of new molecules with potential applications in various fields.
Used in Pharmaceutical Research:
In pharmaceutical research, 5-bromo-2,4-dimethylpyrimidine serves as a key intermediate for the synthesis of drugs with therapeutic properties. Its versatility in chemical reactions enables the production of a wide range of pharmaceutical agents.
Used in Agrochemicals:
5-Bromo-2,4-dimethylpyrimidine is also utilized as a precursor in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals that enhance crop protection and yield.
Used in Specialty Chemicals:
5-broMo-2,4-diMethyl-pyriMidine finds application in the production of specialty chemicals, which are tailored for specific industries and applications, such as dyes, coatings, and advanced materials. Its unique properties make it a valuable component in these specialized chemical formulations.

Check Digit Verification of cas no

The CAS Registry Mumber 69696-37-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,6,9 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 69696-37:
(7*6)+(6*9)+(5*6)+(4*9)+(3*6)+(2*3)+(1*7)=193
193 % 10 = 3
So 69696-37-3 is a valid CAS Registry Number.

69696-37-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-2,4-dimethylpyrimidine

1.2 Other means of identification

Product number -
Other names 5-bromo-2,4-dimethylpyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:69696-37-3 SDS

69696-37-3Relevant academic research and scientific papers

TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

-

, (2018/04/11)

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein.

IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER

-

, (2018/04/12)

A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein.

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

-

, (2016/07/27)

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

CHEMICAL COMPOUNDS

-

Page/Page column 131, (2013/07/05)

The invention is directed to substituted quinoline derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R1, R2, R3; R4; and R5 are defined herein. The compounds of the invention are inhibitors of lactate dehydrogenase A and can be useful in the treatment of cancer and diseases associated with tumor cell metabolism, such as cancer, and more specifically cancers of the breast, colon, prostate and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting lactate dehydrogenase A activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 69696-37-3